Healthcare real estate investors are adjusting their view of risk this year, not their belief in demand. Liquidity is gathering around core and specialty assets, even as capital providers keep a tight grip on terms.
Capital Returns, But On New Terms
Partner Valuation Advisors describes a 2026 market in which the bid for healthcare is back, but only for the right assets and the right sponsors. High occupancy and durable income across much of the sector have not changed, but the way investors underwrite those attributes has. Instead of stretching on price, they are recalibrating risk thresholds while assuming that need‑based healthcare demand remains intact.
That shift is most evident in how equity and debt are behaving. Financing conditions have eased since the most volatile period of the past two years, with lender spreads compressing and credit becoming more readily available to qualified borrowers.
Yet capital remains selective, favoring assets with clear utilization, strong alignment with health systems or physician groups, and locations that would be difficult to replicate. The willingness to lend and invest is back, but the discipline around what counts as "core" has tightened.
Liquidity Pools Around Core And Specialty
The transaction markets underscore this repricing of risk rather than demand. Large, institutional‑grade medical office and hospital‑adjacent properties continue to change hands at meaningful prices, reflecting the value placed on mission‑critical facilities.
In early 2026, for example, county and health system buyers stepped up for key assets such as a major San Jose healthcare campus and a suburban Chicago hospital pavilion, paying high per‑square‑foot figures that signal conviction about long‑term utilization.
At the same time, investors are not allocating capital evenly across the sector. Liquidity has concentrated at the top of the quality spectrum, with core and core‑plus assets drawing the most attention, while secondary properties face longer marketing periods and tighter scrutiny. This bifurcation is less about whether patients will keep using the buildings and more about whether sponsors, lenders and equity are comfortable with the credit, functionality and strategic relevance of each asset.
Specialty segments, particularly behavioral health and inpatient rehabilitation, have moved from niche strategies to central parts of the thesis for many investors. Partner Valuation Advisors highlights growing capital flows into these need‑based assets, driven by demographic growth, rising clinical demand and limited new supply.
Here again, risk is being repriced—operators and real estate capital are digging deeper into operator quality, reimbursement exposure and lease structures—but the underlying demand story is rarely in question.
Medical Office As The Risk Benchmark
Medical office continues to set the benchmark for what investors consider acceptable risk in healthcare real estate. National occupancy has stayed in the low‑90s for years, with modest but persistent rent growth. That consistency has made medical office the reference point against which more specialized assets are judged.
In this environment, well‑located, institutionally sized medical office buildings with strong tenancy are attracting steady interest and financing. Investors are less inclined to push prices to pre‑2022 levels, but they are willing to accept lower yields on assets that combine stable utilization with clear alignment with health system strategies and outpatient care trends.
For many, these buildings serve as the "core within core" in their healthcare allocation: the place where they are most comfortable putting money to work as they recalibrate risk elsewhere in their portfolios.
A Cautious Opening In Development
Development is also reflecting the same theme. Projects are resurfacing, but almost exclusively where the demand case is hard to dispute. Developers and their capital partners are advancing outpatient and specialty care facilities that extend existing care networks, relieve capacity constraints or support long‑term strategic shifts by major providers.
Elevated construction costs and higher capital costs have not derailed these projects, but they have raised the bar for what moves forward. Proposals that cannot demonstrate sustained utilization, durable tenancy and a clear role in a health system's footprint are struggling to secure financing.
Where those boxes are checked, however, capital is willing to engage, suggesting that investors view demand as reliable enough to justify new supply, provided the risk profile is firmly underwritten.
The 2026 Investor Playbook
For healthcare real estate investors, Partner Valuation Advisors' read of 2026 points toward a straightforward, if demanding, playbook. Focus on assets—whether core medical office, hospital‑adjacent facilities or specialty settings—where the demand story is need‑based and defensible over time. Spend more effort on understanding operator quality, lease and reimbursement structures, and the asset's role in the local delivery system.
The sector is not being written off; it is being re‑sorted. Capital that sat on the sidelines is returning, but with a clearer hierarchy of acceptable risk. In that sense, this year is less about questioning whether patients will keep showing up, and more about deciding which buildings, operators and capital structures can carry that demand through the next phase of the cycle.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.